CAREGEN CO.,LTD. Logo

CAREGEN CO.,LTD.

Develops biomimetic peptides and growth factors for aesthetic and medical solutions.

214370 | KO

Overview

Corporate Details

ISIN(s):
KR7214370009
LEI:
Country:
South Korea
Address:
경기도 안양시 동안구 엘에스로91번길 46-38, 안양시

Description

Caregen Co., Ltd. is a global biotechnology company specializing in the research, development, and commercialization of biomimetic peptides and growth factors. As a leader in peptide synthesis, the company leverages its world-class, patented technologies to create innovative products. Its portfolio provides comprehensive solutions for the anti-aging, aesthetic, and cosmeceutical sectors, with applications targeting skin pigmentation, inflammation, hair care, and weight management. The company's research focuses on developing peptide-based therapeutics and total health care solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2019-03-18 00:00
주권매매거래정지기간변경(상장폐지 사유 발생)
Korean 4.7 KB
2019-03-18 00:00
기타시장안내(상장폐지 사유 발생)
Korean 3.2 KB
2019-03-15 00:00
조회공시요구(풍문또는보도)에대한답변(미확정)
Korean 5.9 KB
2019-03-15 00:00
주권매매거래정지기간변경(풍문 사유(감사의견 비적정설) 미해소)
Korean 5.1 KB
2019-03-14 00:00
조회공시요구(풍문또는보도)(감사의견 비적정설)
Korean 3.5 KB
2019-03-14 00:00
주권매매거래정지(풍문 또는 보도 관련)
Korean 5.0 KB
2019-03-11 00:00
주주총회소집공고
Korean 712.4 KB

Automate Your Workflow. Get a real-time feed of all CAREGEN CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CAREGEN CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CAREGEN CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.